Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084274470> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2084274470 endingPage "373" @default.
- W2084274470 startingPage "373" @default.
- W2084274470 abstract "Pemphigus disorders are a group of serious and potentially life-threatening diseases affecting skin and/or mucus membranes. Dexamethasone-cyclophosphamide pulse (DCP) therapy has shown promising results in the management of these diseases.The objective of the study was to assess the outcome of DCP therapy in pemphigus.Pemphigus patients who had been treated with DCP therapy from 2001 to 2008 were prospectively and retrospectively analyzed.A total of 65 pemphigus patients were enrolled. Male to female ratio was 1 : 1.82. Mean age of patients was 44.65 +/- 11.85 years with a range of 14 to 73 years. Thirty two patients completed phase I, of which 28 (9 in phase II, 7 in phase III and 12 in phase III) were maintaining remission and four patients relapsed. Relapse was observed only in patients who discontinued or took irregular treatment. Six patients were declared cured of disease. Five patients died during phase I. Dexamethasone-cyclophosphamide pulse therapy is not absolutely free from adverse effects. Most of the immediate side effects were expected, tolerable and did not pose any problem in continuing treatment. There was a slight increased incidence of weight gain, hypertension, diabetes mellitus, cataract and Cushingoid habitus, since most of our patients also received additional daily oral steroids. Also, there was a high incidence of secondary pyogenic infections of skin lesions and oral candidiasis during phase I. Staphylococcus aureus was the commonest bacteria isolated from the pus of skin lesions. Most of the alterations in laboratory parameters were transitory or correctable, and did not pose a problem in continuing therapy.DCP therapy was found to be effective in inducing and maintaining remission in pemphigus, provided the patients receive regular and complete treatment." @default.
- W2084274470 created "2016-06-24" @default.
- W2084274470 creator A5022819910 @default.
- W2084274470 creator A5049708617 @default.
- W2084274470 date "2009-01-01" @default.
- W2084274470 modified "2023-09-24" @default.
- W2084274470 title "Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: A case series" @default.
- W2084274470 doi "https://doi.org/10.4103/0378-6323.53133" @default.
- W2084274470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19584462" @default.
- W2084274470 hasPublicationYear "2009" @default.
- W2084274470 type Work @default.
- W2084274470 sameAs 2084274470 @default.
- W2084274470 citedByCount "14" @default.
- W2084274470 countsByYear W20842744702013 @default.
- W2084274470 countsByYear W20842744702014 @default.
- W2084274470 countsByYear W20842744702017 @default.
- W2084274470 countsByYear W20842744702018 @default.
- W2084274470 countsByYear W20842744702021 @default.
- W2084274470 countsByYear W20842744702022 @default.
- W2084274470 crossrefType "journal-article" @default.
- W2084274470 hasAuthorship W2084274470A5022819910 @default.
- W2084274470 hasAuthorship W2084274470A5049708617 @default.
- W2084274470 hasBestOaLocation W20842744701 @default.
- W2084274470 hasConcept C120665830 @default.
- W2084274470 hasConcept C121332964 @default.
- W2084274470 hasConcept C126322002 @default.
- W2084274470 hasConcept C134018914 @default.
- W2084274470 hasConcept C141071460 @default.
- W2084274470 hasConcept C16005928 @default.
- W2084274470 hasConcept C197934379 @default.
- W2084274470 hasConcept C2776694085 @default.
- W2084274470 hasConcept C2776755627 @default.
- W2084274470 hasConcept C2780401358 @default.
- W2084274470 hasConcept C2781327288 @default.
- W2084274470 hasConcept C2909029107 @default.
- W2084274470 hasConcept C555293320 @default.
- W2084274470 hasConcept C61511704 @default.
- W2084274470 hasConcept C71924100 @default.
- W2084274470 hasConcept C90924648 @default.
- W2084274470 hasConceptScore W2084274470C120665830 @default.
- W2084274470 hasConceptScore W2084274470C121332964 @default.
- W2084274470 hasConceptScore W2084274470C126322002 @default.
- W2084274470 hasConceptScore W2084274470C134018914 @default.
- W2084274470 hasConceptScore W2084274470C141071460 @default.
- W2084274470 hasConceptScore W2084274470C16005928 @default.
- W2084274470 hasConceptScore W2084274470C197934379 @default.
- W2084274470 hasConceptScore W2084274470C2776694085 @default.
- W2084274470 hasConceptScore W2084274470C2776755627 @default.
- W2084274470 hasConceptScore W2084274470C2780401358 @default.
- W2084274470 hasConceptScore W2084274470C2781327288 @default.
- W2084274470 hasConceptScore W2084274470C2909029107 @default.
- W2084274470 hasConceptScore W2084274470C555293320 @default.
- W2084274470 hasConceptScore W2084274470C61511704 @default.
- W2084274470 hasConceptScore W2084274470C71924100 @default.
- W2084274470 hasConceptScore W2084274470C90924648 @default.
- W2084274470 hasIssue "4" @default.
- W2084274470 hasLocation W20842744701 @default.
- W2084274470 hasLocation W20842744702 @default.
- W2084274470 hasLocation W20842744703 @default.
- W2084274470 hasLocation W20842744704 @default.
- W2084274470 hasOpenAccess W2084274470 @default.
- W2084274470 hasPrimaryLocation W20842744701 @default.
- W2084274470 hasRelatedWork W1487746867 @default.
- W2084274470 hasRelatedWork W1753485997 @default.
- W2084274470 hasRelatedWork W2003232189 @default.
- W2084274470 hasRelatedWork W2004640566 @default.
- W2084274470 hasRelatedWork W2052457199 @default.
- W2084274470 hasRelatedWork W2093554044 @default.
- W2084274470 hasRelatedWork W2110334588 @default.
- W2084274470 hasRelatedWork W2164212853 @default.
- W2084274470 hasRelatedWork W2528259868 @default.
- W2084274470 hasRelatedWork W295883138 @default.
- W2084274470 hasVolume "75" @default.
- W2084274470 isParatext "false" @default.
- W2084274470 isRetracted "false" @default.
- W2084274470 magId "2084274470" @default.
- W2084274470 workType "article" @default.